GRP
CATX icon

Global Retirement Partners’s Perspective Therapeutics CATX Stock Holding History

Global Retirement Partners’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$9.56K Buy
3,476
+922
+36% +$2.63K ﹤0.01% 3173
2025
Q3 		$8.76K Buy
+2,554
New +$9.31K ﹤0.01% 2751

Other funds holding CATX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
NWMG
Nicholson Wealth Management Group Charlestown, South Carolina $172M AUM 10.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Global Retirement Partners's CATX Position: Q4 2025 in Review

Global Retirement Partners increased its Perspective Therapeutics (CATX) stake by 36% in Q4 2025, buying an estimated $2.63K and bringing the position to 3,476 shares worth $9.56K. The position accounts for ﹤0.01% of the portfolio, ranked #3173.

Global Retirement Partners first reported a position in CATX in Q3 2025 and has held it in 2 quarters since. 117 funds tracked by Wall St. Rank hold CATX as of Q4 2025.

  • Global Retirement Partners held 3,476 shares of Perspective Therapeutics worth $9.56K as of Q4 2025.
  • Global Retirement Partners bought 922 Perspective Therapeutics shares in Q4 2025, an estimated $2.63K.
  • Perspective Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #3173 holding.
  • Global Retirement Partners first reported a position in Perspective Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • 117 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.